1-Butanol

CAS No. 71-36-3

1-Butanol( —— )

Catalog No. M19029 CAS No. 71-36-3

1-Butanol has an antioxidant effect, can decrease hyperglycemia. 1-Butanol has anti-allergic inflammatory effects by inhibiting the degranulation of mast cells and the expression of inflammatory cytokines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Butanol
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Butanol has an antioxidant effect, can decrease hyperglycemia. 1-Butanol has anti-allergic inflammatory effects by inhibiting the degranulation of mast cells and the expression of inflammatory cytokines.
  • Description
    1-Butanol has an antioxidant effect, can decrease hyperglycemia. 1-Butanol has anti-allergic inflammatory effects by inhibiting the degranulation of mast cells and the expression of inflammatory cytokines. 1-Butanol significantly protects dopaminergic neurons from MPP(+)-induced degradation and reveals the potential neuroprotective mechanism of 1-Butanol. 1-Butanol has cytoprotective effect in I/R-caused myocyte mortality was involved with the mitigation of ROS, prohibition of the activation of ERK, JNK and caspase-8, and elevation of Hsp70 and Bcl-2/Bax ratio.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    71-36-3
  • Formula Weight
    74.12
  • Molecular Formula
    C4H10O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chandramohan R, et al. Chemico-Biological Interactions, 2015, 229:44-54.
molnova catalog
related products
  • Patritumab

    Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.

  • SCH-772984

    A novel potent and selective inhibitor of ERK1/ERK2 with IC50 of 4 nM/1 nM, respectively.

  • AZ6197

    AZ6197 (AZ-6197) is a potent, selective, reversible inhibitor of ERK1/2 with IC50 of <0.3 nM (ERK2).